Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
115
NCT03686657
Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients
Phase: Phase 1/2
Role: Lead Sponsor
Start: Oct 10, 2025
Completion: Jan 31, 2029